Lesson plan

Α-Propyltryptamine

α-Propyltryptamine (APT, αPT, or α-PT) is a chemical compound of the tryptamine and α-alkyltryptamine families. It is the α-propyl derivative of tryptamine and is a higher homologue of α-methyltryptamine (AMT) and α-ethyltryptamine (AET). The compound was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). He noted that it had been synthesized but that it had never been tested in humans to his knowledge. Moreover, he speculated that it would likely require a "pretty hefty dosage" for central effects based on extrapolation from the loss of potency with higher phenethylamine α-homologation like α-propylphenethylamines such as BDP (K).

Back to article

Article summary

α-Propyltryptamine (APT, αPT, or α-PT) is a chemical compound of the tryptamine and α-alkyltryptamine families. It is the α-propyl derivative of tryptamine and is a higher homologue of α-methyltryptamine (AMT) and α-ethyltryptamine (AET). The compound was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). He noted that it had been synthesized but that it had never been tested in humans to his knowledge. Moreover, he speculated that it would likely require a "pretty hefty dosage" for central effects based on extrapolation from the loss of potency with higher phenethylamine α-homologation like α-propylphenethylamines such as BDP (K).

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.